دورية أكاديمية

Subclinical TRAPS treated with canakinumab

التفاصيل البيبلوغرافية
العنوان: Subclinical TRAPS treated with canakinumab
المؤلفون: M. Amatruda, N.S. Carucci, C. Fede, G. Conti
المصدر: Reumatismo, Vol 73, Iss 2 (2021)
بيانات النشر: PAGEPress Publications, 2021.
سنة النشر: 2021
المجموعة: LCC:Medicine
LCC:Internal medicine
مصطلحات موضوعية: TRAPS, IL-1, canakinumab, AA amyloidosis., Medicine, Internal medicine, RC31-1245
الوصف: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is a rare autoinflammatory disease characterized by recurrent episodes of fever and systemic inflammation. We describe the case of a 19-year-old patient who was referred to our attention with frequent subclinical TRAPS episodes characterized by mild arthralgias and crampy abdominal pain, without fever. Inflammatory markers, including serum amyloid A which increases the risk of long-term amyloidosis, were persistently high also when the patient was in good general conditions. Therapy with human anti-interleukin 1β monoclonal antibody, canakinumab, led to disease control and normalization of the inflammatory markers, which are currently still normal. This clinical case supports the need to treat also subclinical TRAPS. In this respect, canakinumab is effective and reduces the risk of developing amyloidosis.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Italian
تدمد: 0048-7449
2240-2683
العلاقة: https://reumatismo.org/index.php/reuma/article/view/1406Test; https://doaj.org/toc/0048-7449Test; https://doaj.org/toc/2240-2683Test
DOI: 10.4081/reumatismo.2021.1406
الوصول الحر: https://doaj.org/article/bb60fb069ea445b99c5e8e720f1beafaTest
رقم الانضمام: edsdoj.bb60fb069ea445b99c5e8e720f1beafa
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00487449
22402683
DOI:10.4081/reumatismo.2021.1406